2 New Malaria Treatments Announced as Drug Resistance Grows

Pharmalittle: We're reading about Trump and patent policies, a new malaria drug, and more

Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are enveloping the Pharmalot campus, where the official mascots are dozing after chasing varmints and keeping the neighbors honest. As for us, we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today is mint chocolate chip) and foraging for items of interest. On that note, here are a few tidbits to …

Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains

Phase 3 results for the Novartis malaria drug “GanLum” show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years. The post Novel Novartis Malaria Drug Shows Promise to Become New Asset Against Resistant Strains appeared first on MedCity News.

2 new malaria treatments announced as drug resistance grows

Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based Novartis has released results for a new experimental drug called GanLum.

Scientists create new anti-malaria drug with ‘very high cure rate’

Experts said they were "very excited" by the findings

Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

Novartis, with study success, to seek approval of new kind of malaria drug

The treatment — which could be the first novel antimalarial in decades — showed the ability in testing to combat drug resistance and slow disease transmission.